IGC Pharma, Inc. Common Stock — Cash Flow (NYSE:IGC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -10.8 M-7.46 M-7.05 M-5.2 M-4.79 M -5.45 M Cash from investing activities 3.39 M-742 K-235 K-317 K-442 K -106 K Cash from financing activities 14.69 M4.14 M100 K3.52 M4.45 M 5.48 M Free cash flow -10.8 M-7.46 M-7.05 M-5.2 M-5.28 M -6.23 M

News

electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates

4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates

Merck KGaA (MKKGY) Lags Q4 Earnings Estimates

Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - ReAlpha Tech (NASDAQ:AIRE), BeyondSpring (NASDAQ:BYSI)

Explainer-How US marijuana reclassification could help cannabis companies

Why MillerKnoll Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Akanda (NASDAQ:AKAN), Actelis Networks (NASDAQ:ASNS)

India Capital Growth Fund receives redemption requests for 20.1% of shares

IGC Pharma earnings matched, revenue fell short of estimates

Earnings call transcript: IGC Pharma’s Q2 2025 results highlight Alzheimer’s trial progress

IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates

Luckin Coffee, Aramark, James Hardie and more to report earnings Monday

Profound Medical (PROF) Reports Q3 Loss, Tops Revenue Estimates